Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
Rapid Commun Mass Spectrom ; 24(5): 586-92, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20140976

ABSTRACT

Stable isotope kinetic studies play an important role in the study of very-low density lipoprotein (VLDL) metabolism, including basic and clinical research. Today, [1,1,2,3,3-(2)H(5)]glycerol is the most cost-effective alternative to measure glycerol and triglyceride kinetics. Recycling of glycerol from glycolysis and gluconeogenesis may lead to incompletely labelled tracer molecules. Many existing methods for the measurement of glycerol isotopic enrichment involve the production of glycerol derivatives that result in fragmentation of the glycerol molecule after ionization. It would be favourable to measure the intact tracer molecule since incompletely labelled tracer molecules may be measured as fully labelled. The number of methods available to measure the intact tracer in biological samples is limited. The aim of this project was to develop a gas chromatography/mass spectrometry (GC/MS) method for glycerol enrichment that measures the intact glycerol backbone and is suitable for electron ionization (EI), which is widely available. A previously published method for N-methyl-N-[tert-butyldimethylsilyl]trifluoroacetamide (MTBSTFA) derivatization was significantly improved; we produced a stable derivative and increased recovery 27-fold in standards. We used the optimized MTBSTFA method in VLDL-triglyceride and found that further modification was required to take matrix effects into account. We now have a robust method to measure glycerol isotopic enrichment by GC/EI-MS that can be used to rule out the known problem of tracer recycling in studies of VLDL kinetics.


Subject(s)
Cholesterol, VLDL/chemistry , Fluoroacetates , Glycerol/chemistry , Organosilicon Compounds/chemistry , Triglycerides/chemistry , Acetamides , Cholesterol, VLDL/blood , Cholesterol, VLDL/isolation & purification , Gas Chromatography-Mass Spectrometry/methods , Glycerol/blood , Glycerol/metabolism , Humans , Kinetics , Linear Models , Temperature , Time Factors , Trifluoroacetic Acid/chemistry , Triglycerides/blood
3.
Anal Chim Acta ; 654(1): 85-91, 2009 Nov 03.
Article in English | MEDLINE | ID: mdl-19850173

ABSTRACT

A method based on Asymmetric Flow Field-Flow Fractionation (AF4) was developed to separate different types of lipoproteins from human serum. The emphasis in the method optimization was on the possibilities to characterize the largest lipoprotein fractions (LDL and VLDL), which is usually not possible with the size-exclusion chromatography methods applied in routine analysis. Different channel geometries and flow programs were tested and compared. The use of a short fractionation channel was shown to give less sample dilution at the same fractionation power compared to a conventional, long channel. Different size selectivities were obtained with an exponential decay and a linear cross flow program. The ratio of the UV absorption signal to the light scattering signal was used to validate the relation between retention time and size of the fractionated particles. An experimental setup was developed for the simultaneous determination of the cholesterol and triglycerides distribution over the lipoprotein fractions, based on enzymatic reactions followed by UV detection at 500 nm. Coiled and knitted PTFE tubing reactors were compared. An improved peak sharpness and sensitivity were observed with the knitted tubing reactor. After optimization of the experimental conditions a satisfactory linearity and precision (2-3% rsd for cholesterol and 5-6% rsd for triglycerides) were obtained. Finally, serum samples, a pooled sample from healthy volunteers and samples of sepsis patients, were analyzed with the method developed. Lipoprotein fractionation and cholesterol and triglyceride distributions could be correlated with the clinical background of the samples.


Subject(s)
Cholesterol, LDL/isolation & purification , Cholesterol, VLDL/isolation & purification , Cholesterol/blood , Fractionation, Field Flow/methods , Spectrophotometry, Ultraviolet/methods , Triglycerides/blood , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Enzymes/metabolism , Humans , Lipase/metabolism , Sterol Esterase/metabolism
4.
J Lipid Res ; 43(2): 335-43, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11861676

ABSTRACT

Determination of the circulating levels of plasma lipoproteins HDL, LDL, and VLDL is critical in the assessment of risk of coronary heart disease. More recently it has become apparent that the LDL subclass pattern is a further important diagnostic parameter. The reference method for separation of plasma lipoproteins is ultracentrifugation. However, current methods often involve prolonged centrifugation steps and use high salt concentrations, which can modify the lipoprotein structure and must be removed before further analysis. To overcome these problems we have now investigated the use of rapid self-generating gradients of iodixanol for separation and analysis of plasma lipoproteins. A protocol is presented in which HDL, LDL, and VLDL, characterized by electron microscopy and agarose gel electophoresis, separate in three bands in a 2.5 h centrifugation step. Recoveries of cholesterol and TG from the gradients were close to 100%. The distribution profiles of cholesterol and TG in the gradient were used to calculate the concentrations of individual lipoprotein classes. The values correlated with those obtained using commercial kits for HDL and LDL cholesterol. The position of the LDL peak in the gradient and its shape varied between plasma samples and was indicative of the density of the predominant LDL class. The novel protocol offers a rapid, reproducible and accurate single-step centrifugation method for the determination of HDL, LDL, and VLDL cholesterol, and TG, and identification of LDL subclass pattern.


Subject(s)
Centrifugation, Density Gradient/methods , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Triglycerides/blood , Cholesterol, HDL/isolation & purification , Cholesterol, LDL/isolation & purification , Cholesterol, VLDL/isolation & purification , Humans , Hyperlipidemias/blood , Reproducibility of Results , Triglycerides/isolation & purification , Triiodobenzoic Acids/chemistry
5.
Artif Organs ; 20(4): 332-5, 1996 Apr.
Article in English | MEDLINE | ID: mdl-9139619

ABSTRACT

Extracorporeal removal of low-density lipoprotein (LDL) cholesterol by dextran sulfate adsorption is indicated in patients with diet and drug resistant hyper-cholesterolemia to prevent or to regress coronary heart disease. Plasma separation is the first step in the process, followed by adsorption of LDL cholesterol and lipoprotein (a) (Lp[a]) to negatively charged dextran sulfate covalently bound to cellulose beads. The reduction per treatment in LDL cholesterol is 65-75% and in Lp(a) 40-60%. In most patients one treatment per week is sufficient to reduce mean LDL to 100-150 mg/dl. Minor side effects occur in 2-6% of treatments. Major side effects are rare. In uncontrolled studies long-term treatment was associated with inhibition of progression and induction of regression of coronary artery disease. LDL apheresis by dextran sulfate may increase blood perfusion of some tissues, and preliminary results indicate a beneficial effect on therapy resistant nephrotic syndrome with hypercholesterolemia.


Subject(s)
Cholesterol, LDL/isolation & purification , Hyperlipoproteinemia Type II/therapy , Plasmapheresis , Adsorption , Blood Proteins/isolation & purification , Blood Proteins/metabolism , Cellulose/chemistry , Cellulose/metabolism , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Cholesterol, VLDL/isolation & purification , Dextran Sulfate/chemistry , Dextran Sulfate/metabolism , Humans , Triglycerides/blood , Triglycerides/isolation & purification
6.
Artif Organs ; 20(4): 311-7, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8860712

ABSTRACT

Low-density lipoprotein (LDL) apheresis is applied in patients with coronary heart disease because of severe inherited forms of hypercholesterolemia, for which dietary and combined drug treatment cannot lower LDL cholesterol concentrations less than 130 mg/dl. The following article describes the changes in lipoprotein levels in a total of 19 patients undergoing weekly LDL apheresis. Immunoadsorption, operating with polyclonal antibodies against apolipoprotein B-100, was used in 6 patients. Five patients were put on heparin-induced extracorporeal LDL precipitation (HELP) therapy; 6 received dextran sulfate adsorption treatments. Under steady-state conditions a single treatment reduced LDL cholesterol by 149 + or - 3 mg/dl with immunoadsorption, 122 + or - 2 mg/dl with HELP, and 124 + or - 18 mg/dl with dextran sulfate adsorption. Lipoprotein (a) (Lp[a]) declined by 52 to 65%. Very low density lipoprotein (VLDL) cholesterol and VLDL triglycerides declined by 45 to 55% because of the activation of lipoprotein lipase and precipitation during the HELP procedure. In all procedures, there was a small reduction in the different high-density lipoprotein fractions, which had returned to normal after 24 h. The long-term HDL3 cholesterol levels increased significantly. During all procedures there was a decrease in the molar esterification rate of lecithin cholesterol acyltransferase activity. All changes in lipid fractions were paralleled by changes in the corresponding apolipoprotein levels. It is concluded that all three techniques described are powerful tools capable of lowering LDL cholesterol in severe hereditary forms of hypercholesterolemia. In HELP and dextran sulfate adsorption, the amount of plasma is limited by the elimination of other plasma constituents. Immunoadsorption may thus be preferred in very severe forms of hypercholesterolemia.


Subject(s)
Cholesterol, LDL/isolation & purification , Cholesterol, VLDL/isolation & purification , Hyperlipoproteinemia Type II/therapy , Plasmapheresis/methods , Acyl Coenzyme A/antagonists & inhibitors , Adsorption , Apolipoproteins A/blood , Apolipoproteins A/isolation & purification , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Coronary Angiography , Dextran Sulfate/chemistry , Dextran Sulfate/metabolism , Humans , Immunosorbents , Phosphatidylcholine-Sterol O-Acyltransferase/blood , Plasmapheresis/standards
7.
Metabolism ; 39(5): 468-73, 1990 May.
Article in English | MEDLINE | ID: mdl-2336034

ABSTRACT

The hypothesis that dietary factors in early life modify the extent of adaptive responses in adult life was tested in rats. During the gestational and lactational periods, pregnant rats were fed either a high-fat (HF) or low-fat (LF) diet (corn oil, 15% or 2%, wt/wt) until 30 days postpartum. The offspring were maintained on standard chow for an additional 100 days and fed a HF diet for 1, 3, 7, or 21 days. Upon challenge for 3 days, rats born to dams fed the HF diet showed a more rapid hypercholesterolemic response when compared with rats born to dams fed a LF diet (mean +/- S.D., 151 +/- 14 mg/dL v 122 +/- 6 mg/dL; P less than .001). Higher levels of cholesterol were associated with elevated levels of apolipoprotein (apo) B (24.0 +/- 4 mg/dL v 15.8 +/- 3 mg/dL; P less than .05) and apo E (31.0 +/- 4 mg/dL v 24.7 +/- 3 mg/dL; P less than .05). Further comparison of the hypercholesterolemic response between the two groups of animals showed increases in cholesterol in all major lipoprotein classes, cholesterol enrichment at the expense of triglyceride (TG) in very-low-density lipoprotein (VLDL), and elevation of apo E-containing high-density lipoprotein (HDL). Examination at longer time periods of HF challenge showed that apo E levels of the HF-exposed animals remained elevated compared with similarly challenged rats born to dams fed the LF diet (35 +/- 3.8 mg/dL v 26 +/- 2.7 mg/dL; P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cholesterol/blood , Dietary Fats/administration & dosage , Homeostasis/physiology , Animals , Apolipoproteins E/blood , Apoproteins/blood , Cholesterol, VLDL/isolation & purification , Female , Gestational Age , Lipids/blood , Lipoproteins/blood , Male , Maternal Behavior , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Inbred Strains , Time Factors , Ultracentrifugation
SELECTION OF CITATIONS
SEARCH DETAIL